Medtronic Acquires New Diabetes Technology

Medtronic, Inc. announced at its annual institutional investor and analyst meeting that the company purchased substantially all glucose monitoring assets from PreciSense A/S, a Denmark-based development company focused on continuous glucose monitoring technology.
TradingMarkets